HIV prevention drug subject to 'extremely worrying' delays in England

Truvada prep hiv

People in England are still waiting to access the HIV prevention treatment PrEP, five months after the court of appeal ruled that NHS England was responsible for its funding.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here